Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1399-1410

  Martín, Antonio Ramón ^a   Villegas, Isabel ^a   La Casa, Carmen ^a   Alarcón De La Lastra, Catalina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Apoptosis; COX; Cyclo oxygenase; IL; Interleukin; Interleukin (IL) 1 ; MPO; Myeloperoxidase; Neutrophils; PG; Prostaglandin; Prostaglandin (PG); Resveratrol; TNBS; TNBS (trinitrobenzenesulphonic acid); Trinitrobenzenesulphonic acid; UC; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MYELOPEROXIDASE; POLYPHENOL; PROSTAGLANDIN D2; PROSTAGLANDIN E2; RESVERATROL; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; GRAPE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; COLITIS; FLAVONOIDS; INFLAMMATION; MALE; OXIDATIVE STRESS; PHENOLS; RATS; RATS, WISTAR; STILBENES; VITIS;

EID: 1542285473     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.12.024     Document Type: Article

References (47)

1. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
2. Virgili M., Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 281:2000;123-126.
3. Hung L.M., Chen J.K., Huang S.S., Lee R.S., Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47:2000;549-555.
4. Belguendouz L., Fremont L., Gozzelino M.T. Interaction of trans-resveratrol with plasma lipoproteins. Biochem. Pharmacol. 55:1998;811-816.
5. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:2000;6509-6519.
6. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480:2001;243-268.
7. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60:2000;1539-1548.
8. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59:2000;865-870.
9. Moreno J.J. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J. Pharmacol. Exp. Ther. 294:2000;333-338.
10. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126:1999;673-680.
11. Wadsworth T.L., Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57:1999;941-949.
12. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment. Pharmacol. Ther. 16:2002;1997-2015.
13. Nitta M., Hirata I., Toshina K., Murano M., Maemura K., Hamamoto N., Sasaki S., Yamauchi H., Katsu K. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand. J. Immunol. 56:2002;66-75.
14. Abreu M.T. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4:2002;481-489.
15. Siegmund B. Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. Biochem. Pharmacol. 64:2002;1-8.
16. Rachmilewitz D., Simon P.L., Schwartz L.W., Griswold D.E., Fondacaro J.D., Wasserman M.A. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 971:1989;326-337.
17. Fedorak R.N., Empey L.R., MacArthur C., Jewell L.D. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 98:1990;615-625.
18. Zhong W.W., Burke P.A., Drotar M.E., Chavali S.R., Forse R.A. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide- induced gene expression of cytokines in human macrophages. Immunology. 84:1995;446-452.
19. Ajuebor M.N., Singh A., Wallace J.L. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G238-G244.
20. Mahyar-Roemer M., Katsen A., Mestres P., Roemer K. Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation mitochondrial proliferation and membrane potential collapse. Int. J. Cancer. 94:2001;615-622.
21. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96(3):1989;795-803.
22. Bobin-Dubigeon C., Collin X., Grimaud N., Robert J.M., Le Baut G., Petit J.Y. Effects of tumor necrosis factor-α synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur. J. Pharmacol. 42:2001;103-110.
23. Grisham MB, Beniot JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion on the intestine. In: Packer L, Glazer AE, editors. Methods in enzymology. Oxygen radicals in biological systems. San Diego: Academic Press; 1990. p. 729-41.
24. Jang M., Pezzuto J.M. Effects of resveratrol on 12-O- tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 134:1998;81-89.
25. Jang D.S., Kang B.S., Ryu S.Y., Chang I.M., Min K.R., Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol. 57:1999;705-712.
26. Sartor R.B. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 106:1994;533-539.
27. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J. Surg. 22(4):1998;382-389.
28. Nawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultural rat hepatic stellate cells and Kupffer cells. Hepatology. 27:1998;1265-1274.
29. Gao X., Xu Y.X., Janakiraman N., Chapman R.A., Gautam S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 62:2001;1299-1308.
30. Estrov Z., Shishodia S., Faderl S., Harris D., Van Q., Kantarjian H.M.et al. Resveratrol blocks interleukin-1 β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. 102:2003;987-995.
31. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:2000;6509-6519.
32. Guo X., Liu E.S., Ko J.K., Wong B.C., Ye Y., Lam S., Cho C. Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats. Eur. J. Pharmacol. 41:2001;193-203.
33. Kankuri E., Vaali K., Korpela R., Paakkari I., Vapaatalo H., Moilanen E. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation. 25:2001;301-309.
34. Brzozowski T., Konturek P.C., Konturek S.J., Drozdowicz D., Pajdo R., Pawlik M., Brzozowska I., Hahn E.G. Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress. J. Physiol. (Paris). 94:2000;83-91.
35. Korolkiewicz R.P., Ujda M., Dabkowski J., Ruczynski J., Rekowski P., Petrusewicz J. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats. J. Surg. Res. 109(2):2003;161-169.
36. Li Z.G., Hong T., Shimada Y., Komoto I., Kawabe A., Ding Y., Kaganoi J., Hashimoto Y., Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis. 23:2002;1531-1536.
37. Alarcón de la Lastra C., Martín M.J., Motilva V. Antiulcer and gastroprotective effect of quercetin: a gross and histologic study. Pharmacology. 48:1994;56-62.
38. Torres M.I., García-Martín M., Fernández M.I., Nieto N., Gil A., Ríos A. Experimental colitis induced by trinitrobenzenesulphonic acid. An ultrastructural and histochemical study. Dig. Dis. Sci. 44:1999;2523-2529.
39. Yue G, Lai PS, Yin K, Sun FF, Nagele RG, Liu X, Linask KK, Wang C, Lin KT, Wong PY. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 2001;297:915-25;21:973-6.
40. Yue G, Lai PS, Yin K, Sun FF, Nagele RG, Liu X, Linask KK, Wang C, Lin KT, Wong PY. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 2001;297:915-25;21:973-6.
41. Tardieu D., Jaeg J.P., Deloly A., Corpet D.E., Cadet J., Petit C.R. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis. 21:2000;973.
42. Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res. 523/524:2003;145-150.
43. Hayashibara T., Yamada Y., Nakayama S., Harasawa H., Tsuruda K., Sugahara K., Miyanishi T., Kamihira S., Tomonaga M., Maita T. Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr. Cancer. 44:2002;193-201.
44. Zhou H.B., Yan Y., Sun Y.N., Zhu J.R. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J. Gastroenterol. 9:2003;408-411.
45. Boscolo P., del Signore A., Sabbioni E., Di Gioacchino M., Di Giampaolo L., Reale M., Conti P., Paganelli R., Giaccio M. Effects of resveratrol on lymphocyte proliferation and cytokine release. Ann. Clin. Lab. Sci. 33:2003;226-231.
46. Cal C., Garban H., Jazirehi A., Yeh C., Mizutani Y., Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr. Med. Chem. Anti-Cancer Agents. 3:2003;77-93.
47. Bernhard D., Schwaiger W., Crazzolara R., Tinhofer I., Kofler R., Csordas A. Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 195:2003;193-199.